the robust L. major resistance of C57BL/6 and BIO.D2 strains, and also to the expression or severity of several diseases involving TH1 and TH2 type responses, such as atopy and autoimmunity. We do not however, as some may have interpreted, suggest that this is the only lOcus involved in L. major susceptibility or in other diseases.
The genetic determination of resistance to Leishmania major in mice is a topic of interest to many imMLunologists attempting to link the immunological mechanism with the responsible genes. In this respect, this experimental system is one of the paradigms for genetics of disease susceptibility. Mehmet (4) . Moreover, the most resistant RC strain, CcS-5, received the whole central and telomeric part of chromosome 11 (including the IL-4 locus and the other linked immunologically relevant loci) from the susceptible parent BALB/c (5), indicating that this region cannot be the major factor determining susceptibility of BALB/c mice.
Even in the case that this region of chromosome 11 has some effect on L. major susceptibility, it has by no means been proven that this effect is based on the IL-12 response. We found that the quantitative differences in proliferative T cell response to TCR-mediated activation is also closely linked to this region (6) . This (6) . Similar- ly, BIO.D2 and STS/A may achieve resistance through nonidentical mechanisms.
P. Scott recently found a difference in the mechanism of resistance for C57B1/6 and DBA/J (7). C57BL/6 mice were able to overcome L. major infection even after initial in vivo neutralization of IL-12, whereas DBA were not. This observation suggests that the increased maintenance of IL-12 responsiveness we found in B1O.D2 mice could provide an extra layer of protection in that strain, which if absent (as in DBA/J), could lead to greater dependence on early IL-12 synthesis.
In this way, this locus acts as a disease modifier. The same region of chromosome 11 was recently found to be a modifier in another T 1-and TH2-dependent disease, experimental allergic encephalomyelitis (EAE) (8), controlling its severity, but not its initiation. We have proposed that this locus is a modifier of immune response (THI and TH2), and could contribute to
